Delivery Order SPE2DB25D3020-SPE2DB25FWHCW
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a firm-fixed price of $3,311.50 and a completion date of November 5, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Esbriet 801 mg tablets, a medication used to treat pulmonary fibrosis. The contract has a firm fixed price of $3,425.95 and a period of performance through May 13, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Esbriet 267 mg tablets, with a performance period extending through May 7, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Esbriet 801 mg tablets. The contract is a firm-fixed price agreement with a ceiling value of $13,246.00 and a completion date of August 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,623.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Esbriet 801 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 267 MG TABLET 270S, a pharmaceutical product, with a ceiling value of $3,425.95 and a period of performance through May 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,311.50 delivery order is for the supply of Esbriet 801 mg tablets. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of Esbriet 801 mg tablets and has a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $3,311.50 firm fixed price contract is for the supply of the prescription drug Esbriet 801 mg tablets. The contract has a performance period through May 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the delivery of ESBRIET 801 MG TABLET 90S, a medical product, with a period of performance through January 30, 2025. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...